Tapewire

NYSE · USD

ZBH

ZIMMER BIOMET HOLDINGS, INC.

Export transactions ↓
Tapewire entity
3278
SEC CIK
0001136869
Parsed reports
830

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 5, 2026 20:12 UTC
Campbell Gary CraigPresident, Americas
Exercise / conversionRestricted Stock Units · Derivative 1,218 $0.00 $0.00
Disclosure

SEC source: 0002155115-26-000003 · form4-10052026_081009.xml · derivative · entry 6

Campbell Gary Craig · CIK 0002155115 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,434

Underlying: Common Stock · 1,218 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: One-third of these RSUs vested on October 1, 2026. The remaining RSUs vest one-half on October 1, 2027 and one-half on October 1, 2028.

F3 · derivative.expiration_date: One-third of these RSUs vested on October 1, 2026. The remaining RSUs vest one-half on October 1, 2027 and one-half on October 1, 2028.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:12 UTC
Campbell Gary CraigPresident, Americas
Exercise / conversionRestricted Stock Units · Derivative 2,368 $0.00 $0.00
Disclosure

SEC source: 0002155115-26-000003 · form4-10052026_081009.xml · derivative · entry 5

Campbell Gary Craig · CIK 0002155115 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,368 shares

Expires 2026-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:12 UTC
Campbell Gary CraigPresident, Americas
Tax withholdingCommon Stock 480 $88.42 $42,441.60
Disclosure

SEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 4

Campbell Gary Craig · CIK 0002155115 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,174

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:12 UTC
Campbell Gary CraigPresident, Americas
Exercise / conversionCommon Stock 1,218 $0.00 $0.00
Disclosure

SEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 3

Campbell Gary Craig · CIK 0002155115 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,654

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:12 UTC
Campbell Gary CraigPresident, Americas
Tax withholdingCommon Stock 932 $88.42 $82,407.44
Disclosure

SEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 2

Campbell Gary Craig · CIK 0002155115 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,436

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:12 UTC
Campbell Gary CraigPresident, Americas
Exercise / conversionCommon Stock 2,368 $0.00 $0.00
Disclosure

SEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 1

Campbell Gary Craig · CIK 0002155115 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 00:12 UTC GrantPhantom Stock Units · Derivative 173.901 $0.00 Strike: $89.85 $0.00
Disclosure

SEC source: 0001910621-26-000010 · form4-10022026_081024.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,171.359

Underlying: Common Stock · 173.901 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 00:11 UTC GrantPhantom Stock Units · Derivative 173.901 $0.00 Strike: $89.85 $0.00
Disclosure

SEC source: 0001689392-26-000012 · form4-10022026_081033.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,033.757

Underlying: Common Stock · 173.901 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 00:16 UTC GrantPhantom Stock Units · Derivative 153.033 $0.00 Strike: $89.85 $0.00
Disclosure

SEC source: 0001999146-26-000010 · form4-10022026_081019.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,865.311

Underlying: Common Stock · 153.033 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 9.178 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 00:14 UTC GrantPhantom Stock Units · Derivative 375.626 $0.00 Strike: $89.85 $0.00
Disclosure

SEC source: 0001587868-26-000016 · form4-10022026_081022.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,392.107

Underlying: Common Stock · 375.626 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 32.614 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 00:21 UTC GrantPhantom Stock Units · Derivative 306.066 $0.00 Strike: $89.85 $0.00
Disclosure

SEC source: 0001222676-26-000012 · form4-10022026_081035.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,660.84

Underlying: Common Stock · 306.066 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 00:24 UTC GrantPhantom Stock Units · Derivative 417.363 $0.00 Strike: $89.85 $0.00
Disclosure

SEC source: 0001485164-26-000010 · form4-10022026_081058.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,073.731

Underlying: Common Stock · 417.363 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 49.652 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 00:19 UTC GrantPhantom Stock Units · Derivative 306.066 $0.00 Strike: $89.85 $0.00
Disclosure

SEC source: 0001142083-26-000010 · form4-10022026_081008.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,077.496

Underlying: Common Stock · 306.066 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:24 UTC
Thornal Kevin RGrp Pres-Global Business
SaleCommon Stock 5,691 $92.95 $528,978.45
Disclosure

SEC source: 0001783992-26-000006 · form4-09152026_080921.xml · nonDerivative · entry 1

Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:12 UTC
Phipps Chad FSee remarks below.
SaleCommon Stock 3,000 $98.35 $295,050.00
Disclosure

SEC source: 0001346672-26-000010 · form4-09092026_080951.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · See remarks below.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,231

F1 · balance_after: Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:08 UTC
Desai ChintanPresident, APAC
GrantRestricted Stock Units · Derivative 10,168 $0.00 $0.00
Disclosure

SEC source: 0002136215-26-000006 · form4-08052026_080820.xml · derivative · entry 1

Desai Chintan · CIK 0002136215 · President, APAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,168

Underlying: Common Stock · 10,168 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029.

F2 · derivative.expiration_date: One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029.

Read SEC document
August 01, 2026 Filed Aug 4, 2026 20:18 UTC
Thornal Kevin RGrp Pres-Global Business
Exercise / conversionRestricted Stock Units · Derivative 9,957 $0.00 $0.00
Disclosure

SEC source: 0001783992-26-000004 · form4-08042026_080809.xml · derivative · entry 3

Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,913

Underlying: Common Stock · 9,957 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.

F3 · derivative.expiration_date: One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.

Read SEC document
August 01, 2026 Filed Aug 4, 2026 20:18 UTC
Thornal Kevin RGrp Pres-Global Business
Tax withholdingCommon Stock 4,266 $92.68 $395,372.88
Disclosure

SEC source: 0001783992-26-000004 · form4-08042026_080809.xml · nonDerivative · entry 2

Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,691

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
August 01, 2026 Filed Aug 4, 2026 20:18 UTC
Thornal Kevin RGrp Pres-Global Business
Exercise / conversionCommon Stock 9,957 $0.00 $0.00
Disclosure

SEC source: 0001783992-26-000004 · form4-08042026_080809.xml · nonDerivative · entry 1

Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,957

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 21:44 UTC GrantPhantom Stock Units · Derivative 389.498 $0.00 Strike: $86.65 $0.00
Disclosure

SEC source: 0001587868-26-000012 · form4-07022026_090709.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,983.867

Underlying: Common Stock · 389.498 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 21:43 UTC GrantPhantom Stock Units · Derivative 180.323 $0.00 Strike: $86.65 $0.00
Disclosure

SEC source: 0001910621-26-000008 · form4-07022026_090727.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,990.182

Underlying: Common Stock · 180.323 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:23 UTC GrantPhantom Stock Units · Derivative 317.369 $0.00 Strike: $86.65 $0.00
Disclosure

SEC source: 0001222676-26-000010 · form4-07022026_080747.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,269.443

Underlying: Common Stock · 317.369 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:22 UTC GrantPhantom Stock Units · Derivative 317.369 $0.00 Strike: $86.65 $0.00
Disclosure

SEC source: 0001142083-26-000008 · form4-07022026_080754.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,674.691

Underlying: Common Stock · 317.369 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:22 UTC GrantPhantom Stock Units · Derivative 180.323 $0.00 Strike: $86.65 $0.00
Disclosure

SEC source: 0001689392-26-000010 · form4-07022026_080701.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,842.604

Underlying: Common Stock · 180.323 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:21 UTC GrantPhantom Stock Units · Derivative 432.776 $0.00 Strike: $86.65 $0.00
Disclosure

SEC source: 0001485164-26-000008 · form4-07022026_080717.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,606.716

Underlying: Common Stock · 432.776 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:20 UTC GrantPhantom Stock Units · Derivative 158.684 $0.00 Strike: $86.65 $0.00
Disclosure

SEC source: 0001999146-26-000008 · form4-07022026_080736.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,703.1

Underlying: Common Stock · 158.684 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:31 UTC
Noor JehanzebSee remarks below.
GrantRestricted Stock Units · Derivative 1,857 $0.00 $0.00
Disclosure

SEC source: 0002059755-26-000006 · form4-06032026_080620.xml · derivative · entry 1

Noor Jehanzeb · CIK 0002059755 · See remarks below.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,857

Underlying: Common Stock · 1,857 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing June 1, 2027.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing June 1, 2027.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:35 UTC
Yi SangGroup President, Asia Pacific
SaleCommon Stock 800 $82.66 $66,128.00
Disclosure

SEC source: 0001635943-26-000013 · form4-06022026_080619.xml · nonDerivative · entry 2

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,251

Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:35 UTC
Yi SangGroup President, Asia Pacific
SaleCommon Stock 4,200 $82.64 $347,088.00
Disclosure

SEC source: 0001635943-26-000013 · form4-06022026_080619.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,051

Read SEC document
May 22, 2026 Filed May 27, 2026 20:14 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001485164-26-000006 · form4-05272026_080533.xml · derivative · entry 2

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,757

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:14 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001485164-26-000006 · form4-05272026_080533.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,173.94

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:13 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001166854-26-000002 · form4-05272026_080534.xml · derivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,506

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:13 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001166854-26-000002 · form4-05272026_080534.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,581.562

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 60.604 phantom stock units accrued on April 30, 2026, 57.375 phantom stock units accrued on January 30, 2026, 49.323 phantom stock units accrued on October 31, 2025 and 53.221 phantom stock units accrued on July 31, 2025, in each case under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:12 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001587868-26-000008 · form4-05272026_080549.xml · derivative · entry 2

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,098

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as of a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as of a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:12 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001587868-26-000008 · form4-05272026_080549.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,594.369

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 34.300 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:12 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001999146-26-000006 · form4-05272026_080511.xml · derivative · entry 2

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,991.063

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:12 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001999146-26-000006 · form4-05272026_080511.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,544.416

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 7.812 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:11 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001910621-26-000006 · form4-05272026_080533.xml · derivative · entry 2

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,922.072

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:11 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001910621-26-000006 · form4-05272026_080533.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,809.859

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.662 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:10 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001689392-26-000008 · form4-05272026_080551.xml · derivative · entry 2

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,875

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:10 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001689392-26-000008 · form4-05272026_080551.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,662.281

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 16.937 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:10 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001745891-26-000004 · form4-05272026_080501.xml · derivative · entry 2

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,098

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:10 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001745891-26-000004 · form4-05272026_080501.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,288.638

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director

F4 · balance_after: Includes 21.697 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:09 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001142083-26-000006 · form4-05272026_080517.xml · derivative · entry 2

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,382

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:09 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001142083-26-000006 · form4-05272026_080517.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,357.322

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:08 UTC GrantRestricted Stock Units · Derivative 1,517.274 $0.00 $0.00
Disclosure

SEC source: 0001222676-26-000008 · form4-05272026_080528.xml · derivative · entry 2

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,927

Underlying: Common Stock · 1,517.274 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:08 UTC GrantPhantom Stock Units · Derivative 875.35 $0.00 Strike: $85.68 $0.00
Disclosure

SEC source: 0001222676-26-000008 · form4-05272026_080528.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,952.074

Underlying: Common Stock · 875.35 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:08 UTC
Stellato Paul AVP, Controller, CAO
GrantRestricted Stock Units · Derivative 9,232 $0.00 $0.00
Disclosure

SEC source: 0001714585-26-000010 · form4-05052026_080504.xml · derivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller, CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,232

Underlying: Common Stock · 9,232 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing on May 1, 2027.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing on May 1, 2027.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:03 UTC
Noor JehanzebSee remarks below.
Exercise / conversionRestricted Stock Units · Derivative 6,626 $0.00 $0.00
Disclosure

SEC source: 0002059755-26-000004 · form4-04032026_080411.xml · derivative · entry 3

Noor Jehanzeb · CIK 0002059755 · See remarks below.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,249

Underlying: Common Stock · 6,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F4 · derivative.exercise_date: One-third of the RSUs vested on April 1, 2026. The remaining RSUs vest one-half on each of April 1, 2027 and April 1, 2028.

F4 · derivative.expiration_date: One-third of the RSUs vested on April 1, 2026. The remaining RSUs vest one-half on each of April 1, 2027 and April 1, 2028.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:03 UTC
Noor JehanzebSee remarks below.
Tax withholdingCommon Stock 1,677 $90.67 $152,053.59
Disclosure

SEC source: 0002059755-26-000004 · form4-04032026_080411.xml · nonDerivative · entry 2

Noor Jehanzeb · CIK 0002059755 · See remarks below.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,151

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding on the vesting of restricted stock units ("RSUs").

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.